This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/26/15 - 10:05:58 AM ET (BATS BZX Real-time Price)
GSK Day's Range
GSK 52 Week Range
GSK Business Summary
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide.View GSK key stats
GlaxoSmithKline PLC - GSK - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates GlaxoSmithKline PLC as a
Buy with a ratings score of B.
Report Snippet: We rate GLAXOSMITHKLINE PLC (GSK) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, expanding profit margins, compelling growth in net income and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company shows weak operating cash flow.